Cargando…
Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk
Aim: Cell cycle regulator cyclin D1 (CCND1) is a pivotal regulator for G1/S phase transition, playing a critical part in initiation of carcinogenesis. Triple negative breast cancer comprises a very heterogeneous group of cancer cells, but little is known about what is wrong in the genome of these pa...
Autores principales: | Liu, Liang-Chih, Su, Chen-Hsien, Wang, Hwei-Chung, Chang, Wen-Shin, Tsai, Chia-Wen, Maa, Ming-Chei, Tsai, Chang-Hai, Tsai, Fuu-Jen, Bau, Da-Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
China Medical University
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265020/ https://www.ncbi.nlm.nih.gov/pubmed/25520916 http://dx.doi.org/10.7603/s40681-014-0003-4 |
Ejemplares similares
-
The contributions of the tissue inhibitor of metalloproteinase-1 genotypes to triple negative breast cancer risk
por: Chang, Wen-Shin, et al.
Publicado: (2016) -
Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk
por: Tsai, Chia-Wen, et al.
Publicado: (2018) -
Contribution of Inflammatory Cytokine Interleukin-18 Genotypes to Renal Cell Carcinoma
por: Chang, Wen-Shin, et al.
Publicado: (2019) -
Personalized medicine in Type 2 Diabetes
por: Liao, Wen-Ling, et al.
Publicado: (2014) -
The contribution of XRCC3 genotypes to childhood acute lymphoblastic leukemia
por: Pei, Jen-Sheng, et al.
Publicado: (2018)